News & Views
-
Read More...
Current treatment can be more effective with modern diabetes technology (April 2, 2019 -- RICHMOND, VA) “Clinical inertia causes diabetes to deteriorate in millions of patients,” said Sidney Chan, CEO of ALR Technologies Inc. (OTCPINK: ALRT), the diabetes management company and developer of the ALRT Diabetes Solution. “Even the best treatment facilities in the world have difficultly implementing the current standard of care because they lack the ability to give sufficient attention to every …
-
Read More...
ALRT’s comprehensive diabetes management system could improve outcomes and provide diagnostic tools for diabetes therapies in one of the world’s most critical diabetes markets (October 1, 2018 -- RICHMOND, VA) ALR Technologies Inc. (OTCPINK: ALRT) has signed a Collaboration Agreement with IDEAS DWC LLC. (“IDEAS”), a Dubai-based marketing company, to bring the ALRT Diabetes Solution to the estimated 40 million people with diabetes in the Middle East and North Africa (MENA) region. The …
-
Read More...
ALRT and Aspire Cerebro will collaborate to market ALRT’s comprehensive diabetes management system to Indian pharmaceutical companies and help improve diabetes management. (August 27, 2018 -- RICHMOND, VA) ALR Technologies Inc. (OTCPINK: ALRT) has signed a Memorandum of Understanding with Aspire Cerebro Advertising Ltd. to bring the ALRT Diabetes Solution to India’s estimated 100 million diabetes patients. The arrangement would connect private healthcare facilities in India with global …
-
Read More...
(“Integrated Solution”) The Integrated Solution will include ALRT Diabetes Solution software, blood glucose test supplies and diabetes management administered by Centers of Excellence for Diabetes Care (June 28, 2018 -- RICHMOND, VA) ALR Technologies Inc. (OTCPINK: ALRT) will be offering Integrated Solution to health insurance payers to help their clinical teams deliver best practice diabetes care to insulin dependent and non-insulin dependent patients. Integrated Solution bundles blood …
-
Read More...
The ALRT Diabetes Solution is an enterprise-scale product that allows healthcare systems to implement best practices for diabetes care on large populations of patients - saving lives and money. “REPRESENTS A FUNDAMENTAL SHIFT IN DIABETES CARE” Company assembles three unique components to create a comprehensive product offering, meets with potential investors, and positions itself for market entry. (May 14, 2018 -- RICHMOND, VA) After a busy period of product development and strategic refocus, …
-
Read More...
Details of the patent pending diabetes management system featuring Predictive A1C and Insulin Dose Adjustment (October 16, 2017 -- RICHMOND, VA) Following the recent FDA clearance of the Company’s Insulin Dose Adjustment feature, ALR Technologies Inc. (“ALRT” or the “Company”) is releasing details of its patent pending Predictive A1C innovation added to the ALRT Diabetes Management System. Details of the innovative features are presented in five videos. First, “How Does The ALRT Diabetes …
-
Read More...
Product development underway to add reference doses based on International Diabetes Federation, Australia, Canada, New Zealand and UK Guidelines (September 25, 2017 -- RICHMOND, VA) On September 18, 2017, the United States Food and Drug Administration (FDA) granted clearance to ALR Technologies Inc. (OTCQB: ALRT) for an innovative insulin dose adjustment (IDA) feature of the ALRT diabetes management system. The ALRT system with IDA uses the American Association of Clinical Endocrinologists ( …
-
Read More...
IDA is designed to ensure that patients get an effective and timely insulin dose(s) based on accurate data about their specific needs (September 19, 2017 -- RICHMOND, VA) The United States Food and Drug Administration (FDA) has granted clearance to ALR Technologies Inc. (OTCQB: ALRT) for an innovative insulin dose adjustment (IDA) feature of the ALRT diabetes management system. The ALRT system with IDA uses the American Association of Clinical Endocrinologists (AACE) and American Diabetes …
-
Read More...
Program Yields Significant Improvement in Glycemic Control for Clinics’ Most Challenging Patients (RICHMOND, VA, November 17, 2015) A 10-month pilot of the ALRT remote monitoring system for diabetes by the Kansas City Metropolitan Physician Association (KCMPA) has found significant improvement in glycemic control for those patients who used the system compared to those who dropped out of the pilot. Patients participating in the pilot program of the ALRT system experienced an average A1C …
-
Read More...
ALRT’s Algorithm Helps Physicians Optimize Treatment And Avoid Complications (February 17, 2015 -- RICHMOND, VA) ALR Technologies Inc. (OTCQB: ALRT), a leading remote chronic care management and medical device company, is pleased to announce the submission of a 510(k) application to the U.S. Food and Drug Administration (FDA) for an innovative new addition to the Health-e-Connect system that will help busy physicians avoid common insulin dosing errors and remotely manage large populations of …
News: Yes